Covered recipient · General Payments record
ERIC S FRANCIS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$385.04
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $261.76 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $59.72 | 3 |
| GlaxoSmithKline, LLC. | $46.07 | 2 |
| Exact Sciences Corporation | $41.66 | 2 |
| Xeris Pharmaceuticals, Inc. | $20.14 | 1 |
| Amgen Inc. | $16.57 | 1 |
| Esperion Therapeutics, Inc. | $16.53 | 1 |
| DEXCOM, INC. | $16.33 | 1 |
| Medtronic, Inc. | $15.20 | 1 |
| Acerta Pharma LLC | $15.15 | 1 |
| Antares Pharma, Inc. | $14.39 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $16.57 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111577348 | CMS |
| Antares Pharma, Inc. | $14.39 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146458758 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.15 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104716741 | CMS |
| Dexcom, Inc. | $16.33 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153299057 | CMS |
| Esperion Therapeutics, Inc. | $16.53 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129435116 | CMS |
| Exact Sciences Corporation | $21.93 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114661950 | CMS |
| Exact Sciences Corporation | $19.73 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114661956 | CMS |
| GlaxoSmithKline, LLC. | $23.33 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116502367 | CMS |
| GlaxoSmithKline, LLC. | $22.74 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116159936 | CMS |
| Lilly USA, LLC | $22.90 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134972685 | CMS |
| Lilly USA, LLC | $18.74 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134966345 | CMS |
| Lilly USA, LLC | $18.08 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134972176 | CMS |
| Medtronic, Inc. | $15.20 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119331915 | CMS |
| Xeris Pharmaceuticals, Inc. | $20.14 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144594058 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.